Sagaliam Acquisition Corp. announced that it has amended the executed non-binding term sheet for the purchase of Biogenysis Inc. ("BGEN") and Virogentics Inc. ("VIRO"), operating subsidiaries of Enzolytics Inc. amending the combined purchase price to $450,000,000. Additionally, the company announce that Ronnie Richardson, Krystine Miller, and Travis Richardson are joining Board of Directors.
Sagaliam Acquisition Corp.
Equities
SAGA
US78661R1068
Investment Holding Companies
1st Jan change | Capi. | |
---|---|---|
+98.02% | 1.23B | |
+2.57% | 986M | |
+18.81% | 777M | |
+2.01% | 666M | |
+3.23% | 621M | |
-.--% | 600M | |
+8.61% | 528M | |
-.--% | 500M | |
-10.64% | 470M |